🇺🇸 FDA
Patent

US 12194064

Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids

granted A61KA61K31/202A61K31/683

Quick answer

US patent 12194064 (Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids) held by Aker BioMarine Human Ingredients AS expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aker BioMarine Human Ingredients AS
Grant date
Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/202, A61K31/683, A61K31/685, A61K35/612